Temporal expression of cytokines and B-cell phenotypes during mechanical circulatory support

Amit Iyengar, Nicholas Wisniewski, Oh Jin Kwon, Martin Cadeiras, Mario Deng, Joanna Schaenman, Yael Korin, Richard Shemin, Elaine Reed, Murray Kwon

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Allosensitization during mechanical circulatory support (MCS) is a well-described phenomenon, although its mechanism remains unknown. Although immune-mediated interactions from devices or blood transfusions have been proposed, the role of inflammation in this development is less clear. This study was undertaken to further investigate the temporal association of cytokines and B-cell phenotypes in the MCS population. Methods: Adult patients who received the Heartmate II (Thoratec, Pleasanton, Calif) at our center between September 2012 and March 2015 were prospectively followed after device implantation. Blood draws for anti-human leukocyte antigen (HLA) antibody, cytokine expression, and B-cell immunophenotyping were performed before implantation and for 3 weeks postoperatively. Time courses for cytokines and B-cell subsets were expressed using visual representations of median levels as heat maps, and mixed modeling analysis was used to model changes with time and patient factors. Results: Twenty patients who received the Heartmate II (Thoratec) were analyzed during the study period. Four patients showed measureable levels of anti-HLA antibody during the follow-up period, although 3 of these had evidence of antibodies preoperatively. Analysis of cytokine trends revealed early (interleukin [IL]-6, IL-8, and IL-10) and late peaking (IL-3, IL-4, fibroblast growth factor 2, and CD40L) patterns. Upregulation of switched memory, transitional, and plasma blast B cells occurred over time. Right ventricular assist device use and low Interagency Registry for Mechanically Assisted Circulatory Support score were associated with decreased mature naive and increased antibody-secreting cells. Conclusions: MCS device implantation was associated with increased inflammatory cytokines and maturation of B-cell phenotypes. No patients developed de novo HLA antibodies, whereas several showed increases in anti-HLA antibody levels detected before implantation. This suggests that inflammation and maturation of existing sensitized B cells might play an important role in the pathogenesis of allosensitization in MCS.

Original languageEnglish (US)
Pages (from-to)155-163
Number of pages9
JournalJournal of Thoracic and Cardiovascular Surgery
Volume159
Issue number1
DOIs
StatePublished - Jan 2020
Externally publishedYes

Fingerprint

HLA Antigens
B-Lymphocytes
Cytokines
Phenotype
Antibodies
Equipment and Supplies
Inflammation
B-Lymphocyte Subsets
Antibody-Producing Cells
Immunophenotyping
CD40 Ligand
Heart-Assist Devices
Interleukin-3
Fibroblast Growth Factor 2
Interleukin-8
Blood Transfusion
Interleukin-4
Interleukin-10
Registries
Interleukin-6

Keywords

  • B-cell maturation
  • device mediated sensitization
  • device-mediated inflammation
  • mechanical circulatory support
  • ventricular assist device

ASJC Scopus subject areas

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Temporal expression of cytokines and B-cell phenotypes during mechanical circulatory support. / Iyengar, Amit; Wisniewski, Nicholas; Kwon, Oh Jin; Cadeiras, Martin; Deng, Mario; Schaenman, Joanna; Korin, Yael; Shemin, Richard; Reed, Elaine; Kwon, Murray.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 159, No. 1, 01.2020, p. 155-163.

Research output: Contribution to journalArticle

Iyengar, A, Wisniewski, N, Kwon, OJ, Cadeiras, M, Deng, M, Schaenman, J, Korin, Y, Shemin, R, Reed, E & Kwon, M 2020, 'Temporal expression of cytokines and B-cell phenotypes during mechanical circulatory support', Journal of Thoracic and Cardiovascular Surgery, vol. 159, no. 1, pp. 155-163. https://doi.org/10.1016/j.jtcvs.2019.03.061
Iyengar, Amit ; Wisniewski, Nicholas ; Kwon, Oh Jin ; Cadeiras, Martin ; Deng, Mario ; Schaenman, Joanna ; Korin, Yael ; Shemin, Richard ; Reed, Elaine ; Kwon, Murray. / Temporal expression of cytokines and B-cell phenotypes during mechanical circulatory support. In: Journal of Thoracic and Cardiovascular Surgery. 2020 ; Vol. 159, No. 1. pp. 155-163.
@article{99de104f4ff042b2980394eb30524ff8,
title = "Temporal expression of cytokines and B-cell phenotypes during mechanical circulatory support",
abstract = "Background: Allosensitization during mechanical circulatory support (MCS) is a well-described phenomenon, although its mechanism remains unknown. Although immune-mediated interactions from devices or blood transfusions have been proposed, the role of inflammation in this development is less clear. This study was undertaken to further investigate the temporal association of cytokines and B-cell phenotypes in the MCS population. Methods: Adult patients who received the Heartmate II (Thoratec, Pleasanton, Calif) at our center between September 2012 and March 2015 were prospectively followed after device implantation. Blood draws for anti-human leukocyte antigen (HLA) antibody, cytokine expression, and B-cell immunophenotyping were performed before implantation and for 3 weeks postoperatively. Time courses for cytokines and B-cell subsets were expressed using visual representations of median levels as heat maps, and mixed modeling analysis was used to model changes with time and patient factors. Results: Twenty patients who received the Heartmate II (Thoratec) were analyzed during the study period. Four patients showed measureable levels of anti-HLA antibody during the follow-up period, although 3 of these had evidence of antibodies preoperatively. Analysis of cytokine trends revealed early (interleukin [IL]-6, IL-8, and IL-10) and late peaking (IL-3, IL-4, fibroblast growth factor 2, and CD40L) patterns. Upregulation of switched memory, transitional, and plasma blast B cells occurred over time. Right ventricular assist device use and low Interagency Registry for Mechanically Assisted Circulatory Support score were associated with decreased mature naive and increased antibody-secreting cells. Conclusions: MCS device implantation was associated with increased inflammatory cytokines and maturation of B-cell phenotypes. No patients developed de novo HLA antibodies, whereas several showed increases in anti-HLA antibody levels detected before implantation. This suggests that inflammation and maturation of existing sensitized B cells might play an important role in the pathogenesis of allosensitization in MCS.",
keywords = "B-cell maturation, device mediated sensitization, device-mediated inflammation, mechanical circulatory support, ventricular assist device",
author = "Amit Iyengar and Nicholas Wisniewski and Kwon, {Oh Jin} and Martin Cadeiras and Mario Deng and Joanna Schaenman and Yael Korin and Richard Shemin and Elaine Reed and Murray Kwon",
year = "2020",
month = "1",
doi = "10.1016/j.jtcvs.2019.03.061",
language = "English (US)",
volume = "159",
pages = "155--163",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Temporal expression of cytokines and B-cell phenotypes during mechanical circulatory support

AU - Iyengar, Amit

AU - Wisniewski, Nicholas

AU - Kwon, Oh Jin

AU - Cadeiras, Martin

AU - Deng, Mario

AU - Schaenman, Joanna

AU - Korin, Yael

AU - Shemin, Richard

AU - Reed, Elaine

AU - Kwon, Murray

PY - 2020/1

Y1 - 2020/1

N2 - Background: Allosensitization during mechanical circulatory support (MCS) is a well-described phenomenon, although its mechanism remains unknown. Although immune-mediated interactions from devices or blood transfusions have been proposed, the role of inflammation in this development is less clear. This study was undertaken to further investigate the temporal association of cytokines and B-cell phenotypes in the MCS population. Methods: Adult patients who received the Heartmate II (Thoratec, Pleasanton, Calif) at our center between September 2012 and March 2015 were prospectively followed after device implantation. Blood draws for anti-human leukocyte antigen (HLA) antibody, cytokine expression, and B-cell immunophenotyping were performed before implantation and for 3 weeks postoperatively. Time courses for cytokines and B-cell subsets were expressed using visual representations of median levels as heat maps, and mixed modeling analysis was used to model changes with time and patient factors. Results: Twenty patients who received the Heartmate II (Thoratec) were analyzed during the study period. Four patients showed measureable levels of anti-HLA antibody during the follow-up period, although 3 of these had evidence of antibodies preoperatively. Analysis of cytokine trends revealed early (interleukin [IL]-6, IL-8, and IL-10) and late peaking (IL-3, IL-4, fibroblast growth factor 2, and CD40L) patterns. Upregulation of switched memory, transitional, and plasma blast B cells occurred over time. Right ventricular assist device use and low Interagency Registry for Mechanically Assisted Circulatory Support score were associated with decreased mature naive and increased antibody-secreting cells. Conclusions: MCS device implantation was associated with increased inflammatory cytokines and maturation of B-cell phenotypes. No patients developed de novo HLA antibodies, whereas several showed increases in anti-HLA antibody levels detected before implantation. This suggests that inflammation and maturation of existing sensitized B cells might play an important role in the pathogenesis of allosensitization in MCS.

AB - Background: Allosensitization during mechanical circulatory support (MCS) is a well-described phenomenon, although its mechanism remains unknown. Although immune-mediated interactions from devices or blood transfusions have been proposed, the role of inflammation in this development is less clear. This study was undertaken to further investigate the temporal association of cytokines and B-cell phenotypes in the MCS population. Methods: Adult patients who received the Heartmate II (Thoratec, Pleasanton, Calif) at our center between September 2012 and March 2015 were prospectively followed after device implantation. Blood draws for anti-human leukocyte antigen (HLA) antibody, cytokine expression, and B-cell immunophenotyping were performed before implantation and for 3 weeks postoperatively. Time courses for cytokines and B-cell subsets were expressed using visual representations of median levels as heat maps, and mixed modeling analysis was used to model changes with time and patient factors. Results: Twenty patients who received the Heartmate II (Thoratec) were analyzed during the study period. Four patients showed measureable levels of anti-HLA antibody during the follow-up period, although 3 of these had evidence of antibodies preoperatively. Analysis of cytokine trends revealed early (interleukin [IL]-6, IL-8, and IL-10) and late peaking (IL-3, IL-4, fibroblast growth factor 2, and CD40L) patterns. Upregulation of switched memory, transitional, and plasma blast B cells occurred over time. Right ventricular assist device use and low Interagency Registry for Mechanically Assisted Circulatory Support score were associated with decreased mature naive and increased antibody-secreting cells. Conclusions: MCS device implantation was associated with increased inflammatory cytokines and maturation of B-cell phenotypes. No patients developed de novo HLA antibodies, whereas several showed increases in anti-HLA antibody levels detected before implantation. This suggests that inflammation and maturation of existing sensitized B cells might play an important role in the pathogenesis of allosensitization in MCS.

KW - B-cell maturation

KW - device mediated sensitization

KW - device-mediated inflammation

KW - mechanical circulatory support

KW - ventricular assist device

UR - http://www.scopus.com/inward/record.url?scp=85064893310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064893310&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2019.03.061

DO - 10.1016/j.jtcvs.2019.03.061

M3 - Article

C2 - 31056358

AN - SCOPUS:85064893310

VL - 159

SP - 155

EP - 163

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 1

ER -